Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.22 HKD | -1.74% |
|
-1.89% | -14.33% |
Jun. 28 | CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval | CI |
Jun. 28 | CSPC Pharma's Breast Cancer Drug Gets Approval in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.33% | 9.41B | |
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- CSPC Pharmaceutical Gets Go-Ahead for Clinical Trial of Multiple Myeloma Drug in China